Angels,VC and other funding options – Can your
company attract the capital?
So you have a
product, but how do you know if you should start a company? This presentation will explore the
differences between various fundraising sources and help you determine which funding source is most appropriate to
grow and maximize the exit for
your company.
Can Crowd Funding Help Biotech?
We will discuss how Investment Crowdfunding will address
funding problems common among emerging biotechnology companies. The scarcity of
capital threatens emerging businesses. Nowhere is that clearer than in early-stage
biotechnology, where innovators routinely find it impossible to raise the
capital necessary to generate data and validate concepts. Traditional financing
sources are unavailable or shrinking, only exacerbating the problem. In 2012
Congress overwhelmingly passed the JOBS Act to ease financing of small
businesses. One of the Act’s most important and revolutionary reforms was the
creation of Investment Crowdfunding, where ordinary investors can invest
directly in companies too small to go public. Investment Crowdfunding is Social
Finance, where investors form online communities on platforms like iCrowd.com
to pool their resources, funding investments of common interest. Biotech is
naturally positioned to create communities based on shared interests in
achieving therapeutic goals, creating constituencies of enthusiasts and
investors. But Investment Crowdfunding poses challenges unique to
Biotechnology, particularly with respect to later-round financings. To overcome
these challenges, Investment Crowdfunding platforms like iCrowd must anticipate
and resolve them.
